Viktor Brabec
#133,345
Most Influential Person Now
Researcher
Viktor Brabec's AcademicInfluence.com Rankings
Viktor Brabeccomputer-science Degrees
Computer Science
#5982
World Rank
#6309
Historical Rank
Computational Linguistics
#946
World Rank
#960
Historical Rank
Machine Learning
#1792
World Rank
#1815
Historical Rank
Artificial Intelligence
#2040
World Rank
#2074
Historical Rank
Viktor Brabecmathematics Degrees
Mathematics
#6351
World Rank
#8814
Historical Rank
Measure Theory
#1289
World Rank
#1631
Historical Rank
Download Badge
Computer Science Mathematics
Viktor Brabec's Degrees
- PhD Computer Science ETH Zurich
Similar Degrees You Can Earn
Why Is Viktor Brabec Influential?
(Suggest an Edit or Addition)Viktor Brabec's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. (2006) (338)
- Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. (2005) (333)
- DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. (2003) (286)
- Organometallic half-sandwich iridium anticancer complexes. (2011) (271)
- A potent cytotoxic photoactivated platinum complex (2007) (246)
- DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. (1993) (214)
- DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. (2002) (209)
- Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes. (1995) (197)
- Double‐check probing of DNA bending and unwinding by XPA–RPA: an architectural function in DNA repair (2001) (186)
- DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. (1999) (175)
- Optically pure, water-stable metallo-helical 'flexicate' assemblies with antibiotic activity. (2011) (170)
- Molecular aspects of resistance to antitumor platinum drugs. (2002) (150)
- Metal Antitumor Compounds: The Mechanism of Action of Platinum Complexes (1989) (145)
- Mechanism of the formation of DNA–protein cross-links by antitumor cisplatin (2007) (139)
- DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464 (2002) (127)
- Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. (1992) (122)
- Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. (2005) (122)
- Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides. (1976) (121)
- Photoactivatable Organometallic Pyridyl Ruthenium(II) Arene Complexes (2012) (121)
- Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. (1990) (117)
- Electrochemical behaviour of proteins at graphite electrodes. II. Electrooxidation of amino acids. (1980) (117)
- Cytotoxic platinum coordination compounds. DNA binding agents (2017) (106)
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc04205d (2016) (105)
- Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers (2003) (98)
- The influence of salts andpH on polarographic currents produced by denatured DNA (1970) (96)
- Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes. (2008) (92)
- Dual triggering of DNA binding and fluorescence via photoactivation of a dinuclear ruthenium(II) arene complex. (2007) (89)
- DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. (2003) (89)
- DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. (2003) (88)
- Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents (2018) (87)
- Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated IrIII Complex Conjugated to a Far-Red Emitting Coumarin. (2019) (86)
- DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II). (1993) (85)
- Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells. (2009) (83)
- The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes. (2008) (83)
- DNA interactions of antitumor platinum(IV) complexes. (1995) (82)
- DNA interactions of bifunctional dinuclear platinum(II) antitumor agents. (1997) (82)
- Electrochemical behavior of natural and biosynthetic polynucleotides at the pyrolytic graphite electrode A new probe for studies of polynucleotide structure and reactions (1978) (79)
- DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media. (2008) (79)
- Electrochemical behaviour of proteins at graphite electrodes. I. Electrooxidation of proteins as a new probe of protein structure and reactions. (1980) (79)
- Bifunctional amine-tethered ruthenium(II) arene complexes form monofunctional adducts on DNA. (2007) (77)
- Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464* (2001) (77)
- Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts (2013) (75)
- Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. (2008) (74)
- DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]. (1996) (73)
- Interfacial behavior of adenine and its nucleosides and nucleotides (1979) (72)
- Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media (2001) (71)
- A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases. (2015) (71)
- Sequence Specificity, Conformation, and Recognition by HMG1 Protein of Major DNA Interstrand Cross-links of Antitumor Dinuclear Platinum Complexes* (2000) (70)
- DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media. (2009) (70)
- Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands. (2007) (69)
- Adsorption of single‐stranded and double‐helical polynucleotides on the mercury electrode (1972) (69)
- Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. (1996) (67)
- DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. (2003) (66)
- DNA sensor for the determination of antitumor platinum compounds (2000) (65)
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells. (2015) (64)
- DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)]. (1998) (64)
- Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes. (1992) (64)
- Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells. (2012) (63)
- Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts. (2002) (63)
- Adjusting the DNA Interaction and Anticancer Activity of Pt(II) N-Heterocyclic Carbene Complexes by Steric Shielding of the Trans Leaving Group. (2015) (63)
- Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. (2007) (62)
- Functionalization of osmium arene anticancer complexes with (poly)arginine: effect on cellular uptake, internalization, and cytotoxicity. (2011) (62)
- Transplatin is cytotoxic when photoactivated: enhanced formation of DNA cross-links. (2006) (62)
- Interfacial behavior of uracil at the mercury-solution interface (1977) (61)
- Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity. (1986) (61)
- The effect of ionic strength on melting of DNA modified by platinum(II) complexes. (1996) (57)
- Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand (2003) (57)
- DNA bending and unwinding due to the major 1, 2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent (2002) (57)
- Emergence of the First Catalytic Oligonucleotides in a Formamide-Based Origin Scenario. (2016) (57)
- Recognition of DNA three-way junctions by metallosupramolecular cylinders: gel electrophoresis studies. (2007) (57)
- Thermal and Thermodynamic Properties of Duplex DNA Containing Site-specific Interstrand Cross-link of Antitumor Cisplatin or Its Clinically Ineffective Trans Isomer* (2001) (57)
- A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex. (2014) (57)
- DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands. (2000) (56)
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands. (2014) (55)
- Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA (1990) (55)
- Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins. (1995) (54)
- Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. (1999) (53)
- mer-[Ru(terpy)Cl3] (terpy = 2,2′:6′,2″-terpyridine) shows biological activity, forms interstrand cross-links in DNA and binds two guanine derivatives in a trans configuration (1995) (53)
- Metallohelices with activity against cisplatin-resistant cancer cells; does the mechanism involve DNA binding? (2013) (53)
- Molecular Aspects of Antitumor Effects of a New Platinum(IV) Drug (2006) (53)
- Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand. (2006) (52)
- DNA condensing effects and sequence selectivity of DNA binding of antitumor noncovalent polynuclear platinum complexes. (2014) (52)
- Ferrocenyl-Coupled N-Heterocyclic Carbene Complexes of Gold(I): A Successful Approach to Multinuclear Anticancer Drugs. (2016) (52)
- Chiral discrimination in platinum anticancer drugs. (2002) (52)
- How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole. (2012) (49)
- Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand. (2010) (49)
- Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin. (2016) (48)
- Novel antitumor cisplatin and transplatin derivatives containing 1-methyl-7-azaindole: synthesis, characterization, and cellular responses. (2015) (47)
- Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity (2012) (47)
- A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464 (2002) (46)
- Raman scattering from nucleic acids adsorbed at a silver electrode. (1985) (46)
- Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II). (1996) (45)
- Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand. (2014) (44)
- Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups (2000) (44)
- 434 — Electrochemical behaviour of proteins at graphite electrodes: Part III. The effect of protein adsorption (1981) (43)
- Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex (2003) (43)
- Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of Antitumor trans-[PtCl2(NH3)(thiazole)] (2005) (42)
- DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin. (1999) (42)
- Interaction of nucleic acids with electrically charged surfaces. VI. A comparative study on the electrochemical behaviour of native and denatured DNAs at graphite electrodes. (1979) (41)
- Electrochemical oxidation of nucleic acids and proteins at graphite electrode. Qualitative aspects (1980) (41)
- 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents. (2012) (41)
- Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine. (2008) (41)
- Exploring the Effect of Polypyridyl Ligands on the Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents. (2018) (41)
- Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)]. (2012) (40)
- Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation. (1994) (40)
- DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+. (1998) (40)
- Potential and structure controlled interfacial behavior of uracil derivatives. (1978) (39)
- Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex. (2016) (39)
- DNA modifications by antitumor trans-[PtCl2(E-iminoether)2]. (1997) (39)
- Combined theoretical and computational study of interstrand DNA guanine-guanine cross-linking by trans-[Pt(pyridine)2] derived from the photoactivated prodrug trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2]. (2012) (38)
- Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts (2018) (38)
- Differences in the cellular response and signaling pathways between cisplatin and monodentate organometallic Ru(II) antitumor complexes containing a terphenyl ligand. (2011) (38)
- cis-Pt I2(NH3)2: a reappraisal. (2015) (38)
- Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)]. (2011) (37)
- Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects. (2017) (37)
- New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry. (2017) (36)
- Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein. (2003) (36)
- Interaction of dinuclear ruthenium(II) supramolecular cylinders with DNA: sequence-specific binding, unwinding, and photocleavage. (2008) (35)
- Substitution-inert trinuclear platinum complexes efficiently condense/aggregate nucleic acids and inhibit enzymatic activity. (2014) (35)
- Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds. (2015) (35)
- Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization. (2016) (34)
- Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes. (1999) (33)
- DNA binding of dinuclear iron(II) metallosupramolecular cylinders. DNA unwinding and sequence preference (2008) (32)
- Different Recognition of DNA Modified by Antitumor Cisplatin and Its Clinically Ineffective trans Isomer by Tumor Suppressor Protein p53* (2001) (32)
- A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton. (2019) (32)
- DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand. (2004) (32)
- Antitumor carboplatin is more toxic in tumor cells when photoactivated: enhanced DNA binding (2012) (31)
- Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair. (2011) (31)
- Nucleic acid analysis by voltammetry at carbon electrodes (1981) (31)
- Electrochemical oxidation of polyadenylic acid at graphite electrodes (1978) (31)
- Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity. (2015) (31)
- Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity. (2008) (30)
- Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand. (2005) (30)
- L-methionine inhibits reaction of DNA with anticancer cis-diamminedichloroplatinum(II). (2002) (30)
- Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates (2017) (30)
- Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex. (2001) (30)
- Thermal stability and energetics of 15‐mer DNA duplex interstrand crosslinked by trans‐diamminedichloroplatinum(II) (2005) (30)
- Raman spectroscopy of DNA modified by intrastrand cross-links of antitumor cisplatin. (2007) (29)
- Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles. (2010) (29)
- Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies. (2006) (29)
- Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents. (2017) (29)
- Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding. (2004) (29)
- Trifunctional dinuclear platinum complexes as DNA-protein cross-linking agents. (2004) (29)
- Effects of monofunctional adducts of platinum(II) complexes on thermodynamic stability and energetics of DNA duplexes. (2005) (28)
- Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold. (2016) (27)
- The realtion between the polarographic behaviour of DNA and its conformation in solution. (1972) (27)
- Recognition of DNA bulges by dinuclear iron(II) metallosupramolecular helicates (2014) (27)
- Experimental techniques in bioelectrochemistry (1995) (27)
- Biophysical studies on the stability of DNA intrastrand cross-links of transplatin. (2008) (27)
- Thermodynamic and mechanistic insights into translesion DNA synthesis catalyzed by Y-family DNA polymerase across a bulky double-base lesion of an antitumor platinum drug. (2012) (27)
- Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent. (2005) (26)
- Tröger's base scaffold in racemic and chiral fashion as a spacer for bisdistamycin formation. Synthesis and DNA binding study (2006) (26)
- Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites. (2016) (25)
- DNA adducts of cisplatin, transplatin and platinum-intercalating drugs. (1994) (25)
- Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action. (2017) (25)
- Studies on cellular accumulation of satraplatin and its major metabolite JM118 and their interactions with glutathione. (2010) (25)
- Chemistry and Structural Biology of 1,2-Interstrand Adducts of Cisplatin (2000) (24)
- Recognition of DNA modified by trans‐[PtCl2NH3(4‐hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex (2006) (24)
- Unique DNA binding mode of antitumor trinuclear tridentate platinum(II) compound. (2011) (23)
- Influence of adsorbability of denatured deoxyribo-nucleic acid on its polarographic reducibility (1974) (23)
- DNA conformation and repair of polymeric natural DNA damaged by antitumor azolato-bridged dinuclear Pt(II) complex. (2012) (23)
- Interactions of nucleic acids with electrically charged surfaces (1978) (23)
- Design, Preparation, and Characterization of Zn and Cu Metallopeptides Based On Tetradentate Aminopyridine Ligands Showing Enhanced DNA Cleavage Activity. (2015) (23)
- Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro. (2010) (23)
- Platinum determination in cis-dichlorodiammineplatinum(II)--DNA complexes by differential pulse polarography. (1984) (23)
- DNA interactions of new antitumor aminophosphine platinum(II) complexes. (1999) (23)
- Iron(II) supramolecular helicates interfere with the HIV-1 Tat–TAR RNA interaction critical for viral replication (2016) (23)
- Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells (2013) (23)
- New spiro tria(thia)zolidine-acridines as topoisomerase inhibitors, DNA binders and cytostatic compounds. (2016) (23)
- Study of thermal and acid denaturation of DNA by means of voltammetry at graphite electrodes (1979) (23)
- Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450 (2009) (22)
- Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA (2010) (22)
- Energetics, conformation, and recognition of DNA duplexes modified by monodentate Ru(II) complexes containing terphenyl arenes. (2010) (22)
- Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: a comparison with the 5'-5' directional isomer. (2009) (22)
- Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand (2005) (22)
- Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors. (2015) (22)
- Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain. (2006) (22)
- Conformational analysis of site-specific DNA cross-links of cisplatin-distamycin conjugates. (2000) (22)
- An Anticancer PtIV Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic Effects. (2019) (22)
- DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects (2008) (21)
- Platinum-DNA interstrand crosslinks: molecular determinants of bending and unwinding of the double helix. (2012) (21)
- Electroanalysis of biomacromolecules (1995) (21)
- Iron(II) supramolecular helicates condense plasmid DNA and inhibit vital DNA-related enzymatic activities. (2015) (21)
- Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells. (2018) (21)
- Interfacial Behavior of D‐Ribose, 2′‐Deoxy‐D‐Ribose, and D‐Ribose 5′‐Phosphate (1978) (21)
- Molecular superoxide radical photogeneration in cancer cells by dipyridophenazine iridium(iii) complexes (2019) (21)
- Biochemical Studies of the Thermal Effects on DNA Modifications by the Antitumor Cisplatin and Their Repair (2007) (20)
- Reinterpretation of fluorescence of terbium ion-DNA complexes. (1989) (20)
- Synthesis, biophysical studies, and antiproliferative activity of platinum(II) complexes having 1,2-bis(aminomethyl)carbobicyclic ligands. (2008) (20)
- Lichen secondary metabolites as DNA-interacting agents. (2014) (20)
- Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells. (2020) (20)
- Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers. (2010) (20)
- DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes (2009) (20)
- Recognition of DNA/RNA bulges by antimicrobial and antitumor metallohelices. (2015) (20)
- Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs (2018) (19)
- Restriction-enzyme cleavage of DNA modified by platinum(II) complexes. (1993) (19)
- Electrochemical analysis of antitumour platinum drugs and their complexes with DNA (1988) (19)
- High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells. (2007) (19)
- An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis (2019) (19)
- Platinum (IV) Derivatives with Cinnamate Axial Ligands Are Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells. (2019) (19)
- Electrochemistry of monoazahemin reconstituted myoglobin at an indium oxide electrode (1997) (19)
- Pulse-polarographic analysis of nucleic acids and proteins (1977) (19)
- Antitumor bifunctional dinuclear PtII complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions (2012) (18)
- Different affinity of nuclear factor‐kappa B proteins to DNA modified by antitumor cisplatin and its clinically ineffective trans isomer (2014) (18)
- Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir III Complex Conjugated to a Far‐Red Emitting Coumarin (2019) (18)
- Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53. (2003) (18)
- Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+. (2009) (18)
- A New Multi-action Pt(IV) Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells. (2020) (18)
- Novel trisubstituted acridines as human telomeric quadruplex binding ligands. (2014) (18)
- Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes (2008) (17)
- Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin. (2004) (17)
- 231 - Adsorption of Mixtures of Complementary and Non-Complementary Nucleic Acid Bases at the Mercury-Solution Interface (1978) (17)
- DNA photocleavage by DNA and DNA-LNA amino acid-dye conjugates. (2010) (17)
- Cellular response to antitumor cis-Dichlorido platinum(II) complexes of CDK inhibitor Bohemine and its analogues. (2012) (17)
- The reducibility of polynucleotides and their a.c. polaro-graphic behaviour (1970) (17)
- Shape-selective recognition of DNA abasic sites by metallohelices: inhibition of human AP endonuclease 1 (2015) (16)
- Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media. (2000) (16)
- Substitution-Inert Polynuclear Platinum Complexes with Dangling Amines: Condensation/Aggregation of Nucleic Acids and Inhibition of DNA-Related Enzymatic Activities. (2019) (16)
- Temperature dependence of the interfacial behavior of uracil derivatives. (1978) (15)
- Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. (2012) (15)
- 2,3‐Diphosphoglycerate Metabolism in Hereditary Spherocytosis (1969) (15)
- DNA interactions of platinum anticancer drugs. Recent advances and mechanisms of action (2005) (15)
- Determination of platinum in urine by differential pulse polarography. (1983) (15)
- New (arene)ruthenium(II) complexes of 4‑aryl‑4H‑naphthopyrans with anticancer and anti-vascular activities. (2018) (15)
- Multiply Intercalator-Substituted Cu(II) Cyclen Complexes as DNA Condensers and DNA/RNA Synthesis Inhibitors. (2018) (14)
- Interactions of platinum complexes containing cationic, bicyclic, nonplanar piperidinopiperidine ligands with biological nucleophiles. (2006) (14)
- New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells. (2019) (14)
- Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues. (2003) (14)
- The effect of combined treatment with platinum complexes and ionizing radiation on DNA in vitro. (1986) (14)
- NMR analysis of duplex d(CGCGATCGCG)2 modified by Λ- and Δ-[Ru(bpy)2(m-GHK)]Cl2 and DNA photocleavage study (2007) (14)
- Differential genotoxic effects of antitumor trans-[PtCl(2)(E-iminoether)(2)] and cisplatin in Escherichia coli. (2002) (14)
- Electrochemical reactions of horse heart cytochrome c at graphite electrodes. (1982) (14)
- 1,2-GG intrastrand cross-link of antitumor dinuclear bifunctional platinum compound with spermidine linker inhibits DNA polymerization more effectively than the cross-link of conventional cisplatin. (2007) (14)
- Adsorption of deoxyribonucleic acid at mercury electrodes from alkaline solutions of higher ionic strength (1983) (14)
- Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells (2018) (13)
- Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage. (2016) (13)
- Substitution-Inert Polynuclear Platinum Complexes That Inhibit the Activity of DNA Polymerase in Triplex-Forming Templates. (2018) (13)
- Induction of immunogenic cell death in cancer cells by a photoactivated platinum(IV) prodrug. (2020) (13)
- Mechanistic insights into toxic effects of a benzotriazolate-bridged dinuclear platinum(II) compound in tumor cells (2012) (13)
- N,N-Dialkylbenzimidazol-2-ylidene platinum complexes - effects of alkyl residues and ancillary cis-ligands on anticancer activity. (2018) (13)
- Copper(ii) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activity. (2019) (12)
- DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin. (2011) (12)
- Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes (2009) (12)
- Discovery of selective, antimetastatic and anti-cancer stem cell metallohelices via post-assembly modification† †Electronic supplementary information (ESI) available: Data created during this study are openly available from the University of Warwick Research Archive Portal (WRAP) (http://wrap.warwic (2019) (12)
- Effect of sulfonamidoethylenediamine substituents in RuII arene anticancer catalysts on transfer hydrogenation of coenzyme NAD+ by formate. (2018) (12)
- DNA interstrand cross-links of an antitumor trinuclear platinum(II) complex: thermodynamic analysis and chemical probing. (2011) (12)
- Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium (2002) (12)
- Enhancing Tumor Cell Response to Chemotherapy through the Targeted Delivery of Platinum Drugs Mediated by Highly Stable, Multifunctional Carboxymethylcellulose-Coated Magnetic Nanoparticles. (2016) (12)
- Internalization of Ineffective Platinum Complex in Nanocapsules Renders It Cytotoxic. (2016) (12)
- In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers (2019) (12)
- Effects of cytotoxic cis- and trans-diammine monochlorido platinum(II) complexes on selenium-dependent redox enzymes and DNA. (2018) (12)
- Interaction of nucleic acids with electrically charged surfaces. VII. The effect of ionic strength of neutral medium on the conformation of dna adsorbed on the mercury electrode. (1980) (12)
- Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemine. (2014) (12)
- Raman scattering from adenine, uracil and their derivatives adsorbed at a silver electrode (1986) (12)
- DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]. (2007) (12)
- A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells (2019) (12)
- Synthesis, characterization and biological evaluation of Co(III) complexes with quinolone drugs. (2019) (11)
- Electrochemical behaviour of proteins at graphite electrodes (1981) (11)
- DNA modified by platinum derivatives cannot adopt the A-form. (1986) (11)
- Thermodynamic properties of damaged DNA and its recognition by xeroderma pigmentosum group A protein and replication protein A. (2006) (11)
- DNA conformational distortion produced by site-specificinterstrand cross-link of trans-diamminedichloroplatinum(II) (1993) (11)
- A metal-free DNA nuclease based on a cyclic peptide scaffold. (2010) (11)
- The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA. (1997) (11)
- Interfacial behaviour of oligoriboadenylates at the mercury-solution interface (1987) (11)
- Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA. (2017) (10)
- Polynuclear Platinum Complexes. Structural Diversity and DNA Binding. (2018) (10)
- Monofunctional and Interstrand DNA Adducts of Platinum(II) Complexes (1994) (10)
- Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? (2021) (10)
- Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments. (1991) (10)
- Electrochemical approach to the mechanism of urea denaturation of horse heart cytochrome c. (1983) (10)
- (Carboxydiamine)Pt(II) complexes of a combretastatin A-4 analogous chalcone: the influence of the diamine ligand on DNA binding and anticancer effects (2011) (10)
- Voltammetry of tobacco mosaic virus and its isolated protein at the graphite electrode. (1985) (10)
- Deoxyribonuclease I footprinting reveals different DNA binding modes of bifunctional platinum complexes (2006) (10)
- The thermodynamics of translesion DNA synthesis past major adducts of enantiomeric analogues of antitumor cisplatin. (2012) (10)
- Thermodynamic impact of abasic sites on simulated translesion DNA synthesis. (2014) (10)
- DNA adducts of the enantiomers of the Pt(II) complexes of the ahaz ligand (ahaz=3-aminohexahydroazepine) and recognition of these adducts by HMG domain proteins. (2005) (10)
- DNA binding of properties of trinuclear platinum complex (1997) (10)
- Substitution-Inert Polynuclear Platinum Complexes Act as Potent Inducers of Condensation/Aggregation of Short Single- and Double-Stranded DNA and RNA Oligonucleotides. (2019) (9)
- Thermodynamics of translesion synthesis across a major DNA adduct of antitumor oxaliplatin: differential scanning calorimetric study. (2012) (9)
- Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis. (1992) (9)
- DNA‐Intercalative Platinum Anticancer Complexes Photoactivated by Visible Light (2021) (9)
- Effects of antitumor derivatives of ineffective transplatin on bacterial cells: Is DNA a pharmacological target? (2015) (9)
- The effect of platinum derivatives on interfacial properties of DNA. (1987) (9)
- Optically Pure Metallohelices That Accumulate in Cell Nuclei, Condense/Aggregate DNA, and Inhibit Activities of DNA Processing Enzymes. (2020) (9)
- Antitumoral effects of mitochondria-targeting neutral and cationic cis-[bis(1,3-dibenzylimidazol-2-ylidene)Cl(L)]Pt(ii) complexes. (2020) (9)
- A Cyclometalated IrIII Complex Conjugated to a Coumarin Derivative Is a Potent Photodynamic Agent against Prostate Differentiated and Tumorigenic Cancer Stem Cells. (2021) (9)
- Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis (2022) (8)
- Oxidation of deoxyribonucleic acid at carbon electrodes. The effect of the quality of the deoxyribonucleic acid sample (1980) (8)
- 78Pt Platinum‐Based Drugs (2005) (7)
- An electrochemical analysis of changes in properties of DNA caused by ionizing and ultraviolet radiations (1980) (7)
- Toxicity in tumor cells, DNA binding mode, and resistance to decomposition by sulfur nucleophiles of new dinuclear bifunctional trans-PtII complexes containing long alkane linkers (2012) (7)
- Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand. (2013) (7)
- Red cell lipids in autoimmune hemolytic anemia. (1969) (7)
- Determination of adsorption isotherms and solute activities from spreading pressure-surface charge data (1977) (7)
- cis-Pt I 2 ( NH 3 ) 2 : a Reappraisal (2015) (7)
- Triazole-based, optically-pure metallosupramolecules; highly potent and selective anticancer compounds. (2020) (7)
- Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA. (2013) (7)
- Metal–nucleic acid interactions (2014) (7)
- "Head-to-head" double-hamburger-like structure of di-ruthenated d(GpG) adducts of mono-functional Ru-arene anticancer complexes. (2016) (7)
- The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions. (2015) (6)
- Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand (2020) (6)
- Red cell carbohydrate metabolism in primary refractory anemias. (1967) (6)
- Preparation of bis(5-phenyltetrazolato) Pt(II) and Pt(IV) analogues of transplatin and in vitro evaluation for antitumor activity (2017) (6)
- Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear PtII complexes (2012) (6)
- Cleavage by restriction enzymes of DNA modified with the antitumour drug cis-diamminedichloroplatinum(II). (1992) (6)
- Role of DNA Repair in Antitumour Effects of Platinum Drugs (2009) (6)
- Polarography of cytochrome c in ammoniacal buffers containing cobalt ions. The effect of the protein conformation. (1985) (6)
- Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl2] analogs (2020) (6)
- Gallium(III) Complex with Cloxyquin Ligands Induces Ferroptosis in Cancer Cells and Is a Potent Agent against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells (2022) (6)
- Interaction of Polyadenylic Acid with the Mercury Electrode (1973) (6)
- Electrochemistry of double-stranded complexes of synthetic polyribonucleotides having interferonogenic and antiviral activity. (1983) (6)
- The effect of anti A antibody on red cell organic phosphates and adenosine triphosphatase activity in vitro. (2009) (6)
- Conformational changes in DNA induced by its adsorption at negatively charged surfaces: The effects of base composition in DNA and the chemical nature of the adsorbent* (1983) (6)
- Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity. (2021) (6)
- Assessment of DNA-binding affinity of cholinesterase reactivators and electrophoretic determination of their effect on topoisomerase I and II activity. (2016) (6)
- Melting of Cross-Linked DNA V. Cross-Linking Effect Caused by Local Stabilization of the Double Helix (2003) (5)
- Antiproliferative Activity and Associated DNA Interactions of [Co2L3]6+ Cylinders Derived from Bis(bidentate) 2-Pyridyl-1,2,3-triazole Ligands (2020) (5)
- Novel cis-Pt(II) Complexes with Alkylpyrazole Ligands: Synthesis, Characterization, and Unusual Mode of Anticancer Action (2022) (5)
- Comment on "Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance" by H. Song, W. Li, R. Qi, L. Yan, X. Jing, M. Zheng and H. Xiao, Chem. Commun., 2015, 51, 11493. (2016) (5)
- Glycoconjugated Metallohelices have Improved Nuclear Delivery and Suppress Tumour Growth In Vivo (2020) (5)
- Synthesis and characterization of (Ru(II), Co(III)) heterobimetallic complexes formed with a 1,10-phenanthroline based hydroxamic acid conjugate (2020) (5)
- Adsorption of human β2,-microglobulin at a water / mercury interface (1988) (4)
- Polarographic activity of the antitumor drug cis-dichlorodiammineplatinum (II). The effect of hydrolysis and trans-isomerization of the drug (1984) (4)
- Adenosine Triphosphatase Activity of the Red Cell Membrane in Paroxysmal Nocturnal Haemoglobinuria (1969) (4)
- Pyruvate kinase-deficiency anemia: membrane approach. (1988) (4)
- Dipyridophenazine iridium(III) complex as a phototoxic cancer stem cell selective, mitochondria targeting agent. (2022) (4)
- On the Biology of Werner's Complex. (2021) (4)
- Structure, chemical reactivity and electromagnetic properties of nucleic acids (1997) (4)
- Polarographie Reduction of Adenine and Cytosine Residues in Denatured DNA (1974) (4)
- Adsorption of bacteriophage on bacterial surface and on the surface of Hg dropping electrode (1967) (4)
- Interaction of nucleic acids with electrically charged surfaces. VI. A comparative study on the electrochemical behaviour of native and denatured DNAs at graphite electrodes. (1975) (4)
- Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes (2016) (4)
- Cationic Fe(II)-Triplex Forming Metallohelices as DNA Bulge Binders. (2020) (4)
- Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights (2017) (4)
- Low-dimensional compounds containing bioactive ligands. Part XV: Antiproliferative activity of tris(5-nitro-8-quinolinolato)gallium(III) complex with noticeable selectivity against the cancerous cells (2020) (4)
- Translesion DNA Synthesis Across Lesions Induced by Oxidative Products of Pyrimidines: An Insight into the Mechanism by Microscale Thermophoresis (2019) (4)
- Stabilization of human telomeric RNA G-quadruplex by the water-compatible optically pure and biologically-active metallohelices (2020) (4)
- Substitution-Inert Polynuclear Platinum Complexes Inhibit Reverse Transcription Preferentially in RNA Triplex-Forming Templates. (2020) (4)
- Relation between differential pulse voltammetric oxidation of polyriboinosinic acid and its structure. (1981) (3)
- Unique structural properties of DNA interstrand cross-links formed by a new antitumor dinuclear Pt(ii) complex. (2017) (3)
- Adenosintriphosphatase activity in hereditary spherocytosis (1967) (3)
- Novel cytotoxic trans-diaminedichloro platinum(II) complexes with nonplanar heterocyclic ligands, preparation, cytotoxicity and DNA binding properties (2003) (3)
- of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action † (2016) (3)
- Trans-diamminedichlorplatinum (II)-modified probes for detection of picogram quantities of DNA. (1992) (3)
- Phosphoinositide signalling system in red blood cells of patients with hereditary spherocytosis. (1991) (3)
- A Multi‐action Pt IV Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells (2020) (3)
- Antitumor bifunctional dinuclear PtII complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions (2011) (3)
- The composition of red cell lipids and the activity of two enzymes of the erythrocyte membrane (ATPase and acetylcholinesterase) in primary refractory anemias. (1969) (3)
- A photoactivated Ir(iii) complex targets cancer stem cells and induces secretion of damage-associated molecular patterns in melanoma cells characteristic of immunogenic cell death (2021) (3)
- Voltammetry of Cytochrome c3 from Desulfovibrio desulfuricans (strain Norway) at the Graphite Electrode (1982) (3)
- 3-[(E)-(acridin-9'-ylmethylidene)amino]-1-substituted thioureas and their biological activity. (2017) (3)
- Antimicrobial activity and DNA/HSA interaction of fluorinated 3,6,9-trisubstituted acridines (2020) (2)
- DNA modification by cisplatin-like Pt(II) complexes containing 1,1′-binaphtyl-2,2′-diamine ligand does not correlate with their antiproliferative activity in cancer cells (2019) (2)
- The demonstration of further enzyme abnormality of the erythrocyte membrane in paroxysmal nocturnal haemoglobinuria: elevated adenosine triphosphatase activity. (1969) (2)
- Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells (2020) (2)
- Interferon inducer, polyriboguanylic.polyribocytidylic acid, inhibits experimental hepatic metastases in mice. (1992) (2)
- DNA Interactions of Novel Platinum Anticancer Drugs (2004) (2)
- Surface Enhanced Raman Scattering Spectroscopy of Flavodoxin on Graphite Electrode with Silver Colloids (1988) (2)
- Antitumor substitution-inert polynuclear platinum complexes stabilize G-quadruplex DNA and suppress G-quadruplex-mediated gene expression (2021) (2)
- Fe(II) metallohelices stabilize DNA G-quadruplexes and down-regulate expression of G-quadruplex regulated oncogenes. (2021) (2)
- Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug? (2022) (2)
- Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells (2018) (2)
- DNA Modifications by Novel Antitumor Platinum Drugs (2002) (2)
- Interfacial behaviour of trideoxyribonucleotide d(CpGpG) and its complex with the antitumour drug cisplatin at the mercury / electrolyte solution interface (1989) (2)
- DNA Interstrand Crosslinks of the Novel Antitumor Trinuclear Platinum Complex BBR3464. Conformation, Recognition by HMG-Domain Proteins and Nucleotide Excision Repair* (2002) (2)
- Translesion DNA synthesis across double-base lesions derived from cross-links of an antitumor trinuclear platinum compound: primer extension, conformational and thermodynamic studies. (2018) (2)
- Crude spectrin extraction from reticulocyte-rich blood samples. (1985) (2)
- DNA Interactions of a Novel Drug, cis[PtCl(NH3)2(N7 -Acyklovir)]+ (1998) (2)
- Shape-selective Targeting on RNA Bulges by Peptidomimetic Metallohelices. (2020) (2)
- [New tests for laboratory diagnosis of spherocytosis]. (1991) (2)
- Thermodynamic Insights by Microscale Thermophoresis into Translesion DNA Synthesis Catalyzed by DNA Polymerases Across a Lesion of Antitumor Platinum–Acridine Complex (2020) (2)
- Metallohelix vectors for efficient gene delivery via cationic DNA nanoparticles (2022) (2)
- A contribution to pathogenesis of secondary anaemias in haemoblastoses. (1960) (2)
- Evaluation of cytotoxic and antitumor effects of a tetravalent analog of carboplatin. (1989) (2)
- Oxidation of cis-diamminediacetato Pt(II) with hydrogen peroxide can give rise to two isomeric Pt(IV) products. (2020) (2)
- A [Pt(cis-1,3-diaminocycloalkane)Cl2] analog exhibits hallmarks typical of immunogenic cell death inducers in model cancer cells. (2021) (2)
- Biophysical studies of the modification of poly(rG) . poly(rC) by cisplatin. Relations to the biological activity of the complex. (1991) (2)
- A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells (2019) (1)
- Biophysical studies of the complexes of polyriboguanylic acid with brominated and chlorinated polyribocytidylic acids. (1991) (1)
- Spectrin oligomers of the red cell membrane extracts in hereditary spherocytosis. (1983) (1)
- [Complement and noncomplement hemolysis of blood cells in patients with various blood diseases after the administration of the crude toxins of Agkistrodon piscivorus, Naja naja, Naja oxiana]. (1984) (1)
- Treatment of malignant lymphomas and lymphadenoses with leukeran. (1959) (1)
- 459—The effect of netropsin on the electrochemical oxidation of DNA at a graphite electrode (1982) (1)
- [ Effect of gamma radiation, cis-diamminedichloroplatinum and its derivates on the Escherichia coli cell survival and potentiality for adaptive response]. (2001) (1)
- Unexpected solution behaviour of ester-functionalized half-sandwich Ru(II) and Ir(III) complexes. (2021) (1)
- [Some biochemical changes in erythrocytes in hereditary spherocytosis]. (1965) (1)
- ANALYSIS OF STRUCTURAL DEFECTS OF POLY(G) POLY(C) COMPLEX (1994) (1)
- Dinuclear Nickel(II) Supramolecular Helicates Down-regulate Gene Expression in Human Cells by Stabilizing DNA G quadruplexes Formed in the Promoter Regions (2022) (1)
- Acidified glycerol lysis test in various haemolytic anaemias. (1990) (1)
- Emergence of the First Catalytic Oligonucleotides in a Formamide-Based Origin Scenario (2016) (1)
- Unusual DNA binding properties of chelate ring-opening platinum complexes (1997) (1)
- Agglutinating phenomenon in the rat sera after administration of methylcellulose. (1980) (1)
- Probing the Thermodynamics of Incorporation of N 6 ‐methyl‐dATP Opposite an Abasic Site, dCMP, and dTMP During Simulated DNA Synthesis by Differential Scanning Calorimetry (2018) (1)
- Antitumor efficient platinum complexes with trans-geometry and their reactions with DNA (2000) (0)
- CCDC 606085: Experimental Crystal Structure Determination (2007) (0)
- Interstrand DNA adducts of platinum complexes (1994) (0)
- [Metabolic changes in erythrocytes in autoimmune hemolytic disease]. (1965) (0)
- [Demonstration of reduction of erythrocyte lipids in autoimmune hemolytic anemia with sensitizaton of the gamma type]. (1968) (0)
- Unchanged binding of 99molybdenum to red cell membrane proteins in hereditary spherocytosis. (1983) (0)
- 銀電極表面に吸着したアデニン,ウラシル,それらの誘導体,および核酸類の表面異常ラマン散乱〔英文〕 (1985) (0)
- Kinetics of Changes in the Secondary Structure of DNA Induced by the Binding of Platinum Cytostatics (1988) (0)
- Rheological evaluation of pathological, perturbed normal and reconstituted red cell membranes. (1990) (0)
- [Biochemical differences between erythrocytes in aplastic anemia and panmyelopathy]. (1968) (0)
- Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates (2017) (0)
- Thermal denaturation of peripheral red cell membrane proteins in relation to heat-induced cell alterations. (1981) (0)
- ctive , antimetastatic and anti-cancer stem cell metallohelices via post-assembly modi fi cation † (2019) (0)
- [Quantitative evaluation of erythropoiesis]. (1967) (0)
- Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity (2012) (0)
- Metal-DNA/RNA interaction (2009) (0)
- Asymmetric triplex metallohelices stabilise DNA G-quadruplexes in promoter oncogene sequences and efficiently reduce their expression in cancer cells (2023) (0)
- Lysis of red blood cells in some haemolytic anaemias--the lytic effect of agkistrodon piscivorus venom in vitro. (1977) (0)
- DNA/LNA and PNA conjugates as gene modifying agents (2011) (0)
- Correction to: Antimicrobial activity and DNA/HSA interaction of fluorinated 3,6,9-trisubstituted acridines (2020) (0)
- The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands (2014) (0)
- [Changes of hemoglobin F and hemoglobin A2 in hematologic diseases]. (1976) (0)
- [Elution of sensitized erythrocytes with chloroquine]. (1990) (0)
- Pt(II) Complex Containing the 1R,2R Enantiomer of trans-1,2-diamino-4-cyclohexene Ligand Effectively and Selectively Inhibits the Viability of Aggressive Pancreatic Adenocarcinoma Cells and Alters Their Lipid Metabolism (2022) (0)
- Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand (2020) (0)
- Modification of DNA by new bis(aminophosphine) complexes ofplatinum(II) in vitro (1998) (0)
- The activity of erythrocyte glucose-6-phosphate dehydrogenase as an indicator of the rate of erythropoiesis (1968) (0)
- Erythropoiesis in leukaemia and malignant lymphomas. (1966) (0)
- Explorer A potent cytotoxic photoactivated platinum complex (2017) (0)
- Adsorption of human beta 2-microglobulin at a water/mercury interface. (1988) (0)
- [Of the red cell deformities in various hemolytic diseases determined by simple filtration method]. (1980) (0)
- Triplex metallohelices have enantiomer-dependent mechanisms of action in colon cancer cells. (2023) (0)
- [METABOLIC CHANGES OF ERYTHROCYTES IN AUTOIMMUNE HEMOLYTIC DISEASE]. (1965) (0)
- On the Biology of Werner's Complex (2021) (0)
- [Stability of erythrocyte lipids in idiopathic autoimmune hemolytic anemia]. (1980) (0)
- Polarographic Reducibility of Polyribouridy tic Acid (1983) (0)
- THE EFFECT OF CIS-DIAMMINEDICHLOROPLATINUM(II) ON THE B TO ATRANSITION OF DNA (1986) (0)
- Study of the Interactions of Anticancer Metal-Based Drugs withDNA. (2001) (0)
- Meet Our Editorial Board Member (2019) (0)
- The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands (2014) (0)
- Reticulocyte-dependent labeling alterations of red cell membrane in pyruvate kinase deficiency anemia. (1987) (0)
- NMR analysis of duplex d(CGCGATCGCG)2 modified by Lambda- and Delta-[Ru(bpy)2(m-GHK)]Cl2 and DNA photocleavage study. (2007) (0)
- [Post-transfusion hemolytic reactions without kidney function disorders]. (1961) (0)
- [Activity of adenosine triphosphatase of the erythrocytic membrane in paroxysmal nacturnal hemoglobinuria]. (1968) (0)
- Meet the Editorial Board Member (2021) (0)
- The decrease of red cell ATP and activation of red cell membrane adenosine triphosphatase due to the immune injury of the erythrocye membrane. (1968) (0)
- Correlation of antitumour properties of platinum compounds with their reactivity towards DNA: An electrochemical study (1985) (0)
- University of Birmingham Effect of sulfonamidoethylenediamine substituents in Ru arene anticancer catalysts on transfer hydrogenation of coenzyme NAD by formate (2018) (0)
- [Spleen erythrocyte pool in hereditary spherocytoses and autoimmune haemolytic anaemias (author's transl)]. (1976) (0)
- [Erythrokinetics in hypoplastic pancytopenias, panmyelopathies and sideroblastic refractory anemias]. (1968) (0)
- [ERYTHROKINETIC EXAMINATION WITH FE59]. (1964) (0)
- [Serological findings in patients with chronic idiopathic form of autoimmune hemolytic anemia]. (1976) (0)
- The A2 hemoglobin in hematological diseases. (1970) (0)
- [Changes in the content of adenosine triphosphate, adenosine, 2,3-diphosphoglycerate and of anorganic phosphate in erythrocytes in hemolytic conditions and refractory anemias]. (1969) (0)
- Organometallics Photoactivatable Organometallic Pyridyl Ruthenium ( II ) Arene Complexes (2011) (0)
- [Immunological studies on the presence of thrombocyte antibodies in paroxysmal nocturnal hemoglobinuria]. (1971) (0)
- AGAROSE-GEL ELECTROPHORESIS OF FRAGMENTS PRODUCED BY DIGESTIONWITH RESTRICTION ENZYMES OF PHC624 DNA MODIFIED BY ANTITUMOURDRUG CISPLATIN (1989) (0)
- [Clinical experiences with a new drug, chlorambucil (CB 1348), in malignant lymphogranuloma]. (1957) (0)
- [On the problem of increased hemolysis in leukemia]. (1961) (0)
- Steric control of DNA interstrand cross-link sites of antitumor trans-platinum complexes (2000) (0)
- [Erythrocytic lipid changes in hereditary spherocytosis (author's transl)]. (1980) (0)
- Energetics, Conformation, and Recognition of DNA Duplexes Modified by Methylated Analogues of ACHTUNGTRENNUNG(PtCl(dien)) + ** (2009) (0)
- [Symptomatic form of autoimmune haemolytic anaemia--serological findings in long-term follow-up patients (author's transl)]. (1980) (0)
- [Evaluation of erythropoietic activity with the aid of radioisotopes]. (1962) (0)
- [Examination of acetylcholinesterase activity of erythrocytes in anemias]. (1968) (0)
- A comparison of DNA binding profiles of bis platinum compoundswith polyamine linkers and a trinuclear platinum phase Iclinical agent (2000) (0)
- [Ektacytometric determination of the deformability of red blood cells in hemolytic anemia with pyruvate kinase deficiency]. (1984) (0)
- LINEARITY ANOMALY IN FERMI DIAGRAM OF P$sup 3$$sup 2$ (1960) (0)
- [On the problem of the cause of spontaneous changes in agglutinability in A-erythrocyte antigen in patients with acute leukemias]. (1961) (0)
- [Our experiences with the treatment of malignant lymphomas]. (1959) (0)
- Ektacytometric assessment of red cell shear induced elongation in some hemolytic disorders (2016) (0)
- A case of the abnormal hemoglobin C. (1981) (0)
- Cover Picture: Synthesis of Chiral Tertiary Alcohols by CuI-Catalyzed Enantioselective Addition of Organomagnesium Reagents to Ketones / Emergence of the First Catalytic Oligonucleotides in a Formamide-Based Origin Scenario / Intermolecular Peptide Cross- (2016) (0)
- Processing and Bypass of a Site-Specific DNA Adduct of the Cytotoxic Platinum–Acridinylthiourea Conjugate by Polymerases Involved in DNA Repair: Biochemical and Thermodynamic Aspects (2021) (0)
- Polarographic Roots of Present Electrochemistry of Proteins and Nucleic Acids (2009) (0)
- [Pyridoxine-responsive congenital sideroblastic anemia]. (1988) (0)
- Cyclometalated Benzimidazole Osmium(II) Complexes with Antiproliferative Activity in Cancer Cells Disrupt Calcium Homeostasis (2023) (0)
- Use of some snake venoms in the diagnostics of paroxysmal nocturnal hemoglobinuria (PNH). (1985) (0)
- [Use of cobra toxin factor in the diagnosis of paroxysmal hemoglobinuria]. (1986) (0)
- [Mechanism of hemolysis in autoimmune hemolytic anemia. Review]. (1977) (0)
- [Hemolytic diseases of the erythrocyte membrane]. (1978) (0)
- Contents list. (2017) (0)
- [Deformability of red blood cells. Physiological, methodological and pathological aspects]. (1983) (0)
- Analysis of erythrocyte rheology by laser light scattering. (1983) (0)
- NMR analysis of duplex d(CGCGATCGCG)2 modified by Λ- and Δ-[Ru(bpy)2(m-GHK)]Cl2 and DNA photocleavage study (2006) (0)
- 553 Activation of trans geometry in bifunctional mononuclear platinum complexes by combining aliphatic and aromatic amines. Mechanistic studies on antitumor action (2004) (0)
- [Glucose-6-phosphate dehydrogenase activity in hemolytic and refractory anemias]. (1966) (0)
- Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells (2013) (0)
- The effect of ionic strength on melting of DNA modified byplatinum(II) complexes (1996) (0)
- A new simple method for determination of erythrocyte filtrability. (1978) (0)
- Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear PtII complexes (2011) (0)
- Antitumor carboplatin is more toxic in tumor cells when photoactivated: enhanced DNA binding (2012) (0)
- [Molecular aspects of the pathogenesis of hereditary spherocytosis]. (1985) (0)
- Metal ions in drug design, neuroscience and disease (2009) (0)
- [Less usual haematological indications for splenectomy (author's transl)]. (1981) (0)
- [Beta thalassemia in pediatric practice. A group of 22 pediatric patients]. (1990) (0)
- [On the pathogenesis of anemia in myelofibrosis]. (1962) (0)
- [Pregnancy in women with autoimmune hemolytic anemia]. (1979) (0)
- Cyclometalated Benzimidazole Osmium(II) Complexes Inhibit the Proliferation of Cancer Cells and Disrupt Calcium Homeostasis (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Viktor Brabec?
Viktor Brabec is affiliated with the following schools:
